Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21903860)

1.

The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption.

Mellis DJ, Itzstein C, Helfrich MH, Crockett JC.

J Endocrinol. 2011 Nov;211(2):131-43. doi: 10.1530/JOE-11-0212. Epub 2011 Sep 8. Review.

2.

The skeleton: no bones about it.

Farquharson C, Staines K.

J Endocrinol. 2011 Nov;211(2):107-8. doi: 10.1530/JOE-11-0274. Epub 2011 Jul 22. No abstract available.

3.

[Bone and Stem Cells. Molecular mechanisms of the differentiation and activation of osteoclasts derived from hematopoietic cells].

Hayashi M, Nakashima T.

Clin Calcium. 2014 Apr;24(4):487-500. doi: CliCa1404487500. Review. Japanese.

PMID:
24681494
4.

Osteoclasts prefer aged bone.

Henriksen K, Leeming DJ, Byrjalsen I, Nielsen RH, Sorensen MG, Dziegiel MH, Martin TJ, Christiansen C, Qvist P, Karsdal MA.

Osteoporos Int. 2007 Jun;18(6):751-9. Epub 2007 Jan 10.

PMID:
17216130
5.

Osteoclast motility: putting the brakes on bone resorption.

Novack DV, Faccio R.

Ageing Res Rev. 2011 Jan;10(1):54-61. doi: 10.1016/j.arr.2009.09.005. Epub 2009 Sep 27. Review.

6.

Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.

Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC.

J Clin Invest. 2008 May;118(5):1858-66. doi: 10.1172/JCI34257.

7.

Recent advances in osteoclast biology and pathological bone resorption.

Blair HC, Athanasou NA.

Histol Histopathol. 2004 Jan;19(1):189-99. Review.

PMID:
14702187
8.

Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.

Väänänen K.

Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. Epub 2005 Apr 15. Review.

PMID:
15876398
9.

Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y.

J Biol Chem. 2012 Jun 1;287(23):19229-41. doi: 10.1074/jbc.M111.323600. Epub 2012 Apr 12.

10.

Therapeutic targeting of osteoclast function and pathways.

Broadhead ML, Clark JC, Dass CR, Choong PF, Myers DE.

Expert Opin Ther Targets. 2011 Feb;15(2):169-81. doi: 10.1517/14728222.2011.546351. Epub 2011 Jan 5. Review.

PMID:
21204734
11.

Bone remodeling and the osteoclast.

Teitelbaum SL.

J Bone Miner Res. 1993 Dec;8 Suppl 2:S523-5. Review.

PMID:
8122522
12.

Advances in osteoclast biology: old findings and new insights from mouse models.

Edwards JR, Mundy GR.

Nat Rev Rheumatol. 2011 Apr;7(4):235-43. doi: 10.1038/nrrheum.2011.23. Epub 2011 Mar 8. Review.

PMID:
21386794
13.

Regulators of osteoclast differentiation and cell-cell fusion.

Miyamoto T.

Keio J Med. 2011;60(4):101-5. Review.

14.

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, Sudo T, Kojima T, Okamoto F, Fukushima H, Okabe K, Ohya K, Ghosh S.

Nat Med. 2004 Jun;10(6):617-24. Epub 2004 May 23.

PMID:
15156202
15.

Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.

Cheng S, Zhao SL, Nelson B, Kesavan C, Qin X, Wergedal J, Mohan S, Xing W.

PLoS One. 2012;7(3):e32887. doi: 10.1371/journal.pone.0032887. Epub 2012 Mar 5.

16.

New regulation mechanisms of osteoclast differentiation.

Nakashima T, Takayanagi H.

Ann N Y Acad Sci. 2011 Dec;1240:E13-8. doi: 10.1111/j.1749-6632.2011.06373.x. Review.

PMID:
22360322
17.

Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

Takahashi M, Mizoguchi T, Uehara S, Nakamichi Y, Yang S, Naramoto H, Yamashita T, Kobayashi Y, Yamaoka M, Furusawa K, Udagawa N, Uematsu T, Takahashi N.

J Bone Miner Metab. 2009;27(1):24-35. doi: 10.1007/s00774-008-0013-y. Epub 2008 Dec 13.

PMID:
19082914
18.

Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.

Buchwald ZS, Kiesel JR, DiPaolo R, Pagadala MS, Aurora R.

PLoS One. 2012;7(6):e38199. doi: 10.1371/journal.pone.0038199. Epub 2012 Jun 6.

19.

Regulatory mechanisms of osteoblast and osteoclast differentiation.

Katagiri T, Takahashi N.

Oral Dis. 2002 May;8(3):147-59. Review.

PMID:
12108759
20.

Regulation of osteoclast function.

Nakamura I, Takahashi N, Jimi E, Udagawa N, Suda T.

Mod Rheumatol. 2012 Apr;22(2):167-77. doi: 10.1007/s10165-011-0530-8. Epub 2011 Sep 28. Review.

PMID:
21953286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk